Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
MARA Q3 Revenue Up 92% YoY, Net Profit Reaches $123 Million

MARA Q3 Revenue Up 92% YoY, Net Profit Reaches $123 Million

Bitget2025/11/05 02:56
By:Bitget

Before the US market opened on November 4th (ET), MARA Holdings reported its Q3 results:

  • Revenue rose 92% year-over-year to $252 million.
  • Net profit swung from a loss of $124.8 million in Q3 2024 to a profit of $123 million.
  • Bitcoin holdings increased 98% year-over-year, reaching 26,747 BTC by the end of Q3 2024, with total holdings rising to 52,850 BTC.

The company successfully turned a profit compared to the year-ago period’s $124.8 million loss, but the earnings did not impress investors. MARA’s stock closed down 5.9% at $16.36. Despite the improvement in profitability, the market had expected even stronger results given MARA’s operating scale.

While revenue rose 92% year-over-year to $252 million, it still missed market estimates by $3.3 million. Earnings per share increased to $0.27, but fell 40% short of the expected $0.45.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

RNA therapy company Adarx Pharmaceuticals (ADRX.US) plans to raise up to $372 million in a U.S. IPO; pharmaceutical giant AbbVie (ABBV.US) has agreed to invest up to $100 million

RNA therapy company Adarx Pharmaceuticals, which is in the late stage of clinical development, plans to raise up to $371.9 million through its initial public offering (IPO) in the United States.

智通财经2026/09/21 16:16